LF-rTMS ameliorates social dysfunction of FMR1-/- mice via modulating Akt/GSK-3β signaling

Biochem Biophys Res Commun. 2021 Apr 23:550:22-29. doi: 10.1016/j.bbrc.2021.02.086. Epub 2021 Mar 5.

Abstract

Autism spectrum disorders (ASD) are a group of neurological disorders which affect approximately 1% of children around the world. Social dysfunction is one of the two core syndromes of ASD, and still lacks effective treatment. Transcranial magnetic stimulation (TMS) is a noninvasive and safe procedure that uses magnetic fields to modulate neural activity. Whether it were effective in modulating social function remains unclear. By using 3-chamber test, ultrasonic vocalization recording and Western-blotting, we demonstrated that FMR1 (fragile X mental retardation protein) mutant mice, a model of ASD, exhibited obvious defects in social preference and ultrasonic communication. In addition, we detected increase of p-Akt (S473) and p-GSK-3β (S9), and decrease of p-PSD-95 (T19) in the anterior cingulate cortex (ACC) of FMR1-/- mice. Treating FMR1-/- mice with 1 Hz repetitive TMS (rTMS) exerted a long lasting effect in improving both the ultrasonic communication and social preference, as well as restoring the levels of Akt/GSK-3β activity and spine density in the FMR1-/-ACC. Our data, for the first time, demonstrated a beneficial effect of low frequency rTMS (LF-rTMS) on the social function of FMR1-/- mice and an involvement of Akt/GSK-3β signaling in this process, indicating LF-rTMS as a potential therapeutic strategy for ASD patients.

Keywords: Akt/GSK-3β signaling; Autism spectrum disorders; Social behavior; Transcranial magnetic stimulation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animal Communication
  • Animals
  • Autism Spectrum Disorder / prevention & control
  • Autism Spectrum Disorder / therapy
  • Female
  • Fragile X Mental Retardation Protein / genetics*
  • Gene Deletion*
  • Glycogen Synthase Kinase 3 beta / metabolism*
  • Gyrus Cinguli / metabolism
  • Male
  • Mice
  • Proto-Oncogene Proteins c-akt / metabolism*
  • Signal Transduction*
  • Social Behavior Disorders / prevention & control*
  • Social Behavior Disorders / therapy*
  • Time Factors
  • Transcranial Magnetic Stimulation*
  • Ultrasonics

Substances

  • Fmr1 protein, mouse
  • Fragile X Mental Retardation Protein
  • Akt1 protein, mouse
  • Glycogen Synthase Kinase 3 beta
  • Gsk3b protein, mouse
  • Proto-Oncogene Proteins c-akt